The Transdermal Drugs Market growth at a CAGR of 5% & expected USD 9.60 billion by 2029. It is analyzed as product type, indication, distribution channel and end-user.

The Janus kinases (JAKs) inhibitor drugs market worth was USD 2.45 billion in 2022 & it will surpass USD 5.11 billion by 2030 showing a CAGR of 9.6% by 2030.

The Psychedelic Drugs Market was valued at USD 2.71 billion in 2023 and is projected to reach USD 7.35 billion, with a CAGR of 13.3% by 2031

Global Purine Analogues Drugs Market, By Drug Type (Cladribine, Tioguanine, Clofarabine, Mercaptopurine, Fludarabine, Nelarabine, Others), End- Users (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Global PEGylated Drugs Market, By Molecule (Protein, FAB’ Fragment, Enzyme and Aptamer), Type (Interferons, Colony Stimulating Factors, Monoclonal Antibodies (mAbs), Other Types), Disease Indication (Gastrointestinal Disorders, Cancer, Multiple Sclerosis, Hepatitis, Other Disease Indications), Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others), Sales Channel (Hospital Pharmacy, Online Provider, Retail Pharmacy), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

The Diuretic Drugs Market grow at a CAGR of 3.50% & expected to reach USD 1.20 billion by 2029. It is categorized by drugs class, route of administration, end user, distribution channel.

The Hepatic Antiviral Drugs Market growth at a CAGR of 4.58% & expected USD 23.05 billion by 2029. It is analyzed as application, drugs, dosage, route of administration, end-users and distribution channel by forecast trends.

Human Insulin Drugs and Delivery Devices Market was valued at USD 50.21 billion in 2023 and will reach USD 94.67 billion, with a CAGR of 8.25% by 2031

Hypercholesterolemia Drugs Market will soar a 16.00% CAGR worth $42.62 billion by 2030. It's divided by Drug Class, End-Users, and Distribution Channel.

Oral Antidiabetic Drugs Market was valued at USD 45 billion in 2021, and it would grow up to USD 57 billion by 2029, growing at a CAGR of 3% during the forecast period.